Sign In
Buy GNOM
$49.01
+0.96 (+1.99%)
At Close: Jun 03, 2026
Can Global X's GNOM Be the Next Big ETF?
02:33pm, Monday, 11'th Jan 2021
Genomics could be the next big thing in the biotechnology space. Similarly, the Global X Genomics & Biotechnology ETF (GNOM) could be the next big fund, and is already up 10% to start the new year.
Top-Performing Biotech ETFs Amid the COVID-19 Crisis
05:18pm, Tuesday, 29'th Dec 2020
The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.
Get On Board a Growing Biotech Industry With the GNOM ETF
06:50pm, Wednesday, 23'rd Dec 2020
It's one thing to discuss the economics of investing in the biotech sector, but it's another to discuss genomics. The sub-sector of the biotech industry has seen strong growth as evidenced by the over
Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up
02:35pm, Monday, 14'th Dec 2020
Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biotechnology Index Fund jumped 4%
An ETF For Every Theme: COVID-19 Lightning Round With Global X (Podcast)
07:00am, Thursday, 30'th Jul 2020
The COVID-19 pandemic has created a massive divergence in performance among thematic ETFs. Among the most pioneering of the thematic ETF issuers, Global X's CEO Luis Berruga joins Let's Talk ETFs to d
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
Biotech ETFs Surge After Invitae Acquires ArcherDX | ETF Trends
09:35pm, Monday, 22'nd Jun 2020
Biotechnology sector-related exchange traded funds were among the leaders on Monday after Invitae Corp. (NYSE: NVTA) announced a $1.4 billion deal for ArcherDX
A Genomics ETF at the Center of the Coronavirus Fight | ETF Trends
04:21pm, Thursday, 18'th Jun 2020
In the scramble to develop a Coronavirus vaccine, genomics investments are receiving renewed attention and rewarding investors in the process.
Genomics: How A Cutting-Edge Field Is Fighting COVID-19
09:05am, Thursday, 18'th Jun 2020
In early January, researchers identified an irregular, lethal pneumonia spreading through China as the disease we now know as COVID-19. Global efforts to identi
Thematic ETFs The New Sectors?
08:00am, Monday, 08'th Jun 2020
Sometimes an idea just gets you thinking about the possibilities.
Thematic ETFs The New Sectors?
12:00am, Monday, 08'th Jun 2020
Sometimes an idea just gets you thinking about the possibilities.
ETFs Under $20 From 5 Hottest Zones
04:20pm, Thursday, 04'th Jun 2020
Let us dig into some of the ETFs that are below $20 and are from the hottest areas currently. These low-priced ETFs could lead to huge gains in the coming months.
3 Genomics ETFs Worth Jumping For
04:50pm, Tuesday, 26'th May 2020
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are deliv
3 Genomics ETFs Worth Jumping For
03:50pm, Tuesday, 26'th May 2020
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced...
Genomics ETF (GNOM) Hits New 52-Week High
11:40am, Tuesday, 26'th May 2020
The ETF GNOM hit a 52-week high on May 22. Can it rally further?
